Haematoncology Flashcards

1
Q

Cancer stem cells accumulate leading to a

A

constant supply of malignant clone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

clonal disorder originates from

A

a single progenitor cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Point mutations include

A

missense
non-sense
frameshift

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Translocation mutations include

A

chimeric genes/proteins

overexpression of a normal cellular gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Genetic abnormalities include

A

poijnt mutations
duplications
translocations
gene and chromosomal deletions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mutated cells acquire characteristics of what cell

A

stem cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what do mutated cells lead to

A

population expansion and avoidance of cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Myeloma is the clonal disorder of what cell

A

plasma cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what does MGUS mean

A

monoclonal gammopathy of undetermined experience

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what antigen experience in myeloma

A

igG or IgA
IgM
kappa/lamda light chain restrictions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

5 things in the anatomy of a plasma cell

A
perinuclear halo/Golgi zone 
Eccentric nucleus 
Clock face nucleus 
Oval cell shape 
Basophilic cytoplasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the drivers of clonal evolution

A

Clonal competition
Tumour microenvironment
Treatment Immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Initiation in Post - GC Bcell what happens

A

hyperdiploidy

IgH translocations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

MGUS to -smm to MM progression inlcudes

A

KRAS mutation
MYC activation
Genomic instability
TP53 inactivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MM to EMD progression

A

secondary genetic events
pattern of mutations
Del (17p) TP53

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical Presentations of Myeloma

A
Normocytic normochromic anaemia (75%)
Bone pain (60%)
Fatigue (30%)
Weight loss (25%)
Renal impairment (15%)
Hyperviscosity 
Recurrent infection s
17
Q

Myeloma is an

A

incurable lymphoid malignancy of post germinal centre of origin

18
Q

Typical findings on a blood film from a patient with myeloma

A

Rouleaux, background staining and in this case thrombocytopenia

19
Q

In blood findings of myeloma the results present and increase in

A

circulating immunoglobulin

20
Q

Bone marrow in myeloma will present

A

an accumulation of malignant plasma cells

21
Q

What components can be use to diagnose the condition of myeloma

A

secretion of immunoglobulin

22
Q

When do Bence jones appear in urine

A

Failure to filter free light chains

23
Q

The 4 things that make up CRAB criteria

A

Hypercalcaemia

Renal impairment = formation o frenal cast; Tamm Horsfall protein

Anaemia

Bone lesions - lytic lesions and pathological fractures

24
Q

What is a frequent finding of patients with myeloma

A

Punched out lesions and fractures

25
Q

Appearance of bone lesions

A

soft and gelatinous like fish flesh

26
Q

stromal cells have the affect of

A

greatly promoting the growth, survival, drug resistance and migration of myeloma.

27
Q

myeloma cells induce stromal cells to

A

to produce RANKL and interleukin -6 which induce proliferation of osteoblasts

28
Q

Myeloma cells also produce what inhibitory factors

A

DKK1, IL-3, soluble frizzle-related protein-2 and IL-7, which suppress osteoblast differentiation and new bone formation. DKK1, Dickkopf; IL, interleukin.

29
Q

myeloma produces what activating factors

A

Myeloma cells produce factors that directly or indirectly activate osteoclasts, such as macrophage inflammatory protein-1α and IL-3.